Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 08-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,222 | -52,540 | -69,417 | -19,292 | -38,644 |
| Depreciation Amortization | 2,836 | 2,663 | 870 | 91 | 211 |
| Income taxes - deferred | 303 | N/A | N/A | N/A | N/A |
| Accounts receivable | -5,973 | -1,274 | -6,181 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,970 | -2,714 | -114 | 3,081 | 754 |
| Other Working Capital | 4,606 | -10,517 | 4,058 | 4,068 | -1,548 |
| Other Operating Activity | 16,321 | 17,401 | 24,188 | 706 | 7,878 |
| Operating Cash Flow | $-44,159 | $-46,981 | $-46,596 | $-11,346 | $-31,349 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 0 | 21,967 | -6,853 | -15,307 |
| PPE Investments | -2,890 | -5,086 | -1,586 | -57 | -385 |
| Net Acquisitions | -35,370 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | 492 | -1,062 | -337 | 6 | -54 |
| Purchase Sale Intangibles | 0 | 0 | -1,250 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -1,250 | 0 | 0 |
| Investing Cash Flow | $-37,768 | $-6,148 | $18,794 | $-6,904 | $-15,746 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 70,000 | 25,000 | 25,000 | N/A |
| Debt Repayment | -9,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 99,896 | 53,044 | 51,195 | 7,982 | 55,537 |
| Other Financing Activity | 0 | -3,677 | -1,386 | -1,934 | 18 |
| Financing Cash Flow | $90,896 | $119,367 | $74,809 | $31,048 | $55,555 |
| Exchange Rate Effect | -1,230 | 323 | -268 | -65 | -52 |
| Beginning Cash Position | 149,613 | 83,052 | 36,313 | 23,580 | 15,172 |
| End Cash Position | 157,352 | 149,613 | 83,052 | 36,313 | 23,580 |
| Net Cash Flow | $7,739 | $66,561 | $46,739 | $12,733 | $8,408 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,159 | -46,981 | -46,596 | -11,346 | -31,349 |
| Capital Expenditure | -2,890 | -5,086 | -1,586 | -57 | -385 |
| Free Cash Flow | -47,049 | -52,067 | -48,182 | -11,403 | -31,734 |